Gut health medtech Atmo Biosciences raises $9.6m to progress ingestible capsule |Malcolm Hebblewhite

Be the First to Comment Read

Gut health medtech Atmo Biosciences raises $9.6m to progress ingestible capsule |Malcolm Hebblewhite

Australian digital health manufacturer Atmo Biosciences has raised AUD 9.6 million and won the support of global pharmaceutical players to meet unmet clinical, consumer and medical device needs. Mr, Malcolm Hebblewhite, the CEO of Atmo Biosciences shares the goals that they are eying after achieving such astounding success.

Disclaimer

Speak your Mind

Ad
kalkine logo

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK